According to various embodiments, there is provided a method for determining a neurological condition of a subject using a robotic system. The robotic system includes a transducer. The method includes determining, by a computing system, a first location with respect to a vessel of the subject, the robotic system configured to position the transducer at the first location. The method further includes receiving, by the computing system, a first signal from the vessel in response to the transducer transmitting acoustic energy towards the vessel. The method further includes analyzing, by the computing system, the received first signal to determine a first parameter of blood flow in the vessel. The method further includes determining, by the computing system, the neurological condition of the subject based on the first parameter of the blood flow in the vessel.

A wearable bladder monitoring device is disclosed and includes a fastener for securing the device to a subject's body; a phased array of ultrasound transducers having configurable output frequencies; a configurable phased array controller adapted to control the phased array to direct ultrasound beams into the subject's body under a plurality of discrete beam angles and to collect echo signals of the ultrasound beams, wherein the phased array controller is adapted to direct a set of ultrasound beams into the subject's body for at least a subset of the discrete beam angles in response to a configuration instruction defining the respective output frequencies of the ultrasound beams in the set; and a device transceiver for communicating data pertaining to the echo signals to a remote device to facilitate the remote processing of the data and to receive the configuration instruction from the remote device.

A system for controlling blood pressure includes a wearable interface having an internal contact surface, the wearable interface configured to at least partially encircle a first portion of a first limb of a subject, a sensing module carried by the wearable interface and configured to determine at least a change in blood pressure of the first limb of the subject, and an energy application module carried by the wearable interface and configured to apply energy of two or more types to the first limb of the subject.

Disclosed is a patient monitor control unit (10) comprising a processor arrangement (11, 13) adapted to receive a series of ultrasound measurements received from a sensor (30) comprising at least one configurable ultrasound transducer; process said series of ultrasound measurements to obtain haemodynamic data of a patient coupled to the sensor; control a patient monitor (20) to display the obtained haemodynamic data; evaluate the obtained haemodynamic data to detect a variance in said data; and generate a reconfiguration signal for the at least one configurable ultrasound transducer, wherein the timing of said generation is a function of said evaluation. Also disclosed are a patient monitoring system, a method of operating a patient monitor control unit and a computer program product for implementing such a method.

A robotic acoustic probe for application with an interventional device (60). The robotic acoustic probe employs an acoustic probe (20) including a imaging platform (21) having a device insertion port (22) defining a device insertion port entry (23) and device insertion port exit (24), and further including an acoustic transducer array (25) are disposed relative the device insertion port exit (24). The robotic acoustic probe further employs a robotic instrument guide (40) including a base (41) mounted to the imaging platform (21) relative to the device insertion port entry (23), and an end-effector (45) coupled to the base (41) and transitionable between a plurality of poses relative to a remote-center-of-motion (49). The end-effector (45) defines an interventional device axis (48) extending through the device insertion port (22), and the remote-center-of-motion (49) is located on the interventional device axis (48) adjacent the device insertion port exit (24).

A wireless system and method for measuring and analyzing blood in a user's body is provided. The system includes a processing, power, and communication component (PPC) having a hardware unit and first housing enclosing the hardware unit; a probe having a piezoelectric crystal and second housing enclosing the piezoelectric crystal; a dock having a sensor and third housing enclosing the sensor. The second housing is spaced apart from the first housing. The third housing is adapted to removably couple to the first housing. The piezoelectric crystal can transmit an ultrasound wave into the body, receive a return ultrasonic wave, convert the return wave into an electrical signal, and transmit the signal to the sensor. The sensor is configured to receive and then transmit the electronic signal to the hardware unit, which is configured to wirelessly transmit a data set based on the electronic signal to a computer device.

Apparatus and methods for diagnosing conditions consistent with the presence of cranial blood vessel blockage and large vessel occlusions (LVO's) using the framework of a small head-harness that is transportable, field-expedient, and durable. A single pulse set using ultrasonic or near-infrared energy is broadcast into a patient's brain allowing the apparatus to perform an area scan of the brain and detect and decipher cranial blood vessel blockage and LVO signal patterns. The interpretation of the pattern lies within the internal programming which produces a binary signal as to whether an LVO is suspected or not.

The disclosure concerns a stretchable garment adapted to be worn by a woman in labor to hold one or more monitoring transducers in place during the course of labor and delivery. It comprises a fabric body that encircles the torso of the woman including her belly and has an aperture which allows access to between L2 and S1 of her lumbar spine.

An ultrasonic thickness measurement device includes: an ultrasonic probe including eight or less ultrasonic elements each including a transmission element and a receiving element, the transmission element and the receiving element being ultrasonic elements; and a controller configured to determine a thickness of target body tissue from tomographic image data of a body of a subject acquired based on a received signal that is received by each of the receiving elements of each of the ultrasonic elements. The controller determines the thickness from the tomographic image data based on each of the received signals that is received by each of the ultrasonic elements.

Systems and method for destroying or inhibiting cancer cells and other rapidly-dividing cells include applying AP magnetic fields having a defined frequency of 5 Hz-500 kHz and a field strength of 0.1-5000 μT to a target body area that includes the cancer or other rapidly-dividing cells, and modifying the cancer or tumor microenvironment to increase the presence of cancer-suppressive cells or decrease the presence of cancer-promoting cells. In various embodiments, the systems and methods may include adjusting the therapy based on the dosage of an immunotherapy drug administered to the patient before, during, or after the application of the AP magnetic fields.